MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
UTHR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

United Therapeutics (UTHR) Ownership - Who owns United Therapeutics?

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Other
Address
1000 Spring Street
Phone
+1 301 608-9292
Employees
1168
Web
https://www.unither.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
24.07B
P/E Ratio
20.97
Total Cash
2.15B
Projected Growth
2.32
Total Debt
200M
Revenue
3.17B
Risk (Beta)
0.36
Dividend Yield
N/A
Total Cash/Share
50.74
Total Debt/Equity
21.97
Revenue/Share
66.66 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
UTHR
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI-Driven Trading for UTHR
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry PharmaceuticalsGeneric

Profile
Details
Industry
Pharmaceuticals Other
Address
1000 Spring Street
Phone
+1 301 608-9292
Employees
1168
Web
https://www.unither.com